Business Context and Reporting Period
This Form 8-K is a current report filed by iSpecimen Inc. on March 3, 2022. The filing addresses corporate governance matters regarding the scheduling of the company's 2022 Annual Meeting of Stockholders and the procedures for shareholder proposals and director nominations.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance announcements and does not contain financial performance data.
Material Changes
There are no material financial changes reported in this filing. The primary event is the Board of Directors' determination of the dates for the 2022 Annual Meeting.
Guidance, Outlook, and Management Commentary
- Annual Meeting Date: The 2022 Annual Meeting of Stockholders is scheduled for Wednesday, May 25, 2022.
- Record Date: The record date for determining stockholders entitled to notice and to vote is set for April 1, 2022.
- Meeting Details: The specific time and location will be disclosed in the definitive proxy statement to be filed with the SEC.
- Shareholder Proposals: Stockholders seeking to bring business before the meeting or nominate director candidates must deliver proposals to the Company's principal executive offices by 5:00 pm ET on March 17, 2022.
- Compliance: Proposals must comply with Delaware law, SEC rules, and the Company's Second Amended and Restated Bylaws.
Key Facts for Investor Verification
- Verify the record date of April 1, 2022, to determine voting eligibility.
- Note the March 17, 2022, deadline for submitting shareholder proposals or director nominations.
- Monitor the upcoming definitive proxy statement for the specific time and location of the May 25, 2022, Annual Meeting.
- Confirm that the company is classified as an emerging growth company.